Use of Clevira tablets and syrup for cough common cold and Flu infections

The requested reference [af589f1189604fb5df0dd0fc677119efb2116fa0] no longer exists in our database. It has been replaced by the current reference: [841603f9aabc59ed298932b95598769473791b42]

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2023
INTERVENTION: Intervention1: Clevira Tablets: 2 tablets Oral Dose Twice a day for 7 to 10 days Intervention2: Clevira Syrup: 10 ml Oral Dose Twice or thrice daily for 7 to 10 days Control Intervention1: Not applicable: Not applicable CONDITION: Health Condition 1: J09X‐ Influenza due to identified novelinfluenza A virus PRIMARY OUTCOME: Difference between Clevira Syrup and standard ; treatment groups in Common cold and cough on ; baseline and Day 10 ; At the end of the study Haematology and vital ; signs (blood pressure, radial pulse rate, body ; temperature and wellbeing status) will be ; recordedTimepoint: Day 0, Day 1 to Day 10 SECONDARY OUTCOME: Not applicableTimepoint: Not applicable INCLUSION CRITERIA: Either se Xbetween the age of 18 to 75 years with an oral temperature of more than 38 C with or without associated rash body pain and joint pain severe headache especially behind the eyes nausea and vomiting Mild to Influenza and other respiratory viral infections Common cold and cough Mumps HPV and Herpes Zoster associated disease as defined by the WHO With Viral fever accompanied by thrombocytopenia with a platelet count between 80000 to 100000 micro litre along with stable vitals like pulse and blood pressure Female patients who tested negative for pregnancy (up to two weeks prior to the study)
Epistemonikos ID: ae5e67c8ccdce251a550e270e4d3f6ad4a3dbe55
First added on: Feb 20, 2024